lobbying_activities: 1345392

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1345392	5dba645e-9c95-4d48-bf53-56f5501641ca	Q4	BAYER CORPORATION (CONSOLIDATED REPORT)	5632	BAYER CORPORATION (CONSOLIDATED REPORT)	2012	fourth_quarter	PHA	H.R. 4223 the "Safe Doses Act"; H.R. 3668 the "Counterfeit Drug Penalty Enhancement Act of 2011"; and H.R. 4216 the "Foreign Counterfeit Prevention Act.", all parts Combat Meth epidemic Act of 2005, sections pertaining to electronic reporting and stop sale Meth Lab Elimination Act of 2010, a draft by Sen. Wyden, all parts relating to pseudoephedrine	HOUSE OF REPRESENTATIVES,SENATE		1150000	0	0	2013-01-18T15:42:17.393000-05:00